Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-123973
Filing Date
2025-05-21
Accepted
2025-05-21 16:05:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d840123ddefa14a.htm DEFA14A 30242
2 GRAPHIC g840123dsp2.jpg GRAPHIC 6534
  Complete submission text file 0001193125-25-123973.txt   40590
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 25973147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)